EDITOR'S PICKS
DEEP DIVES
PE eyes growth opportunities in active pharmaceutical ingredients: 5 deals
Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.
TECH WATCH
HEALTHCARE
SPECIAL REPORTS
INDUSTRIAL/MANUFACTURING
ENERGY/POWER
VOX POPULI
Private equity’s expanding playbook: Accounting and consulting firms
With tens of thousands of CPA firms across the country, investors see consolidation opportunities to build national platforms, write Houlihan Lokey's Matthew Dodd, Patrick Hughes and Shivan Arora.
It’s not just Robert De Niro…
England’s North West, once a by-word for decline, is open for business. Filling significant gaps in the funding ecosystem offers great opportunities for innovative investment – and positive social outcomes, write Palatine's Gary Tipper and Beth Houghton.
Strings attached: navigating legacy with founder and family transitions
Investors need to be nimble in balancing respect for the seller's legacy with the practicalities of operating a business, write Carl Bradshaw and Angus Simpson of law firm Goodwin.
